Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HALIX is an active Dutch contract development and manufacturing organization specializing in GMP production of biologics—including monoclonal antibodies, bispecifics, recombinant proteins—and viral vectors for gene therapies and vaccines. The company operates state-of-the-art facilities at Leiden Bio Science Park with capabilities spanning preclinical to commercial scale. It has played key roles in rapid scale-up projects such as the AstraZeneca COVID‑19 vaccine. As a CDMO it does not have its own clinical pipeline but supports numerous client programs across oncology and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HALIX.